Steroid receptor coactivator-3 glutamine repeat polymorphism and the androgen insensitivity syndrome

European Journal of Endocrinology

Volumn 148, Issue 2, 2003, Pages 277-279

  Mongan, Nigel P ^a   Jääskeläinen, Jarmo ^a   Bhattacharyya, Sumit ^a   Leu, Roberta M ^a   Hughes, Ieuan A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; GLUTAMINE; NUCLEIC ACID BINDING PROTEIN; STEROID RECEPTOR COACTIVATOR 3; UNCLASSIFIED DRUG;

ALLELE; DENYS DRASH SYNDROME; DNA POLYMORPHISM; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HORMONE RESISTANCE; HUMAN; LETTER; MALE; MALE GENITAL SYSTEM DISEASE; MASCULINITY; PRIORITY JOURNAL; RECEPTOR BINDING; SEQUENCE ANALYSIS; VIRILIZATION;

ACETYLTRANSFERASES; ANDROGEN-INSENSITIVITY SYNDROME; GLUTAMINE; HISTONE ACETYLTRANSFERASES; HUMANS; MALE; ONCOGENE PROTEINS; POLYMORPHISM, GENETIC; REPETITIVE SEQUENCES, AMINO ACID; TRANS-ACTIVATORS;

EID: 0037297503     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1480277     Document Type: Letter

References (20)

1. Ahmed SF, Cheng A, Dovey L, Hawkins JR, Martin H, Rowland J et al. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. Journal of Clinical Endocrinology and Metabolism 2000 85 658-665.
2. Brinkmann AO, Blok LJ, de Ruiter PE, Doesburg P, Steketee K, Berrevoets CA et al. Mechanisms of androgen receptor activation and function. Journal of Steroid Biochemistry and Molecular Biology 1999 69 307-313.
3. Lim HN, Chen H, McBride S, Dunning AM, Nixon RM, Hughes IA et al. Longer polyglutamine tracts in the androgen receptor are associated with moderate to severe undermasculinized genitalia in XY males. Human Molecular Genetics 2000 9 829-834.
4. La Spada AR, Wilson EM, Lubahn DB, Harding AE & Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991 352 77-79.
5. Heinlein CA & Chang C. Androgen receptor (AR) coregulators: an overview. Endocrine Reviews 2002 23 175-200.
6. Hsiao PW, Lin DL, Nakao R & Chang C. The linkage of the Kennedy's Neuron Disease to ARA-24, the first identified androgen receptor polyglutamine region-associated coactivator. Journal of Biological Chemistry 1999 274 20229-20234.
7. Batch JA, Williams DM, Davies HR, Brown BD, Evans BA, Hughes IA et al. Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. Human Molecular Genetics 1992 1 497-503.
8. Xu JM, Qiu YH, DeMayo FJ, Tsai SY, Tsai MJ & O'Malley BW. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science 1998 279 1922-1925.
9. Weiss RE, Xu JM, Ning G, Pohlenz J, O'Malley BW & Refetoff S. Mice deficient in the steroid receptor co-activator 1 (SRC-1) are resistant to thyroid hormone. EMBO Journal 1999 18 1900-1904.
10. Xu J, Liao L, Ning G, Yoshida-Komiya H, Deng C & O'Malley BW. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. PNAS 2000 97 6379-6384.
11. New MI, Nimkarn S, Brandon DD, Cunningham-Rundel S, Wilson RC, Newfield RS, Vandermeulen J, Barron N, Russo C, Loriaux DL & O'Malley B. Resistance to several steroids in two sisters. Journal of Clinical Endocrinology and Metabolism 1999 84 4454-4464.
12. Adachi M, Takayanagi R, Tomura A, Imasaki K, Kato S, Goto K et al. Androgen-insensitivity syndrome as a possible coactivator disease. New England Journal of Medicine 2000 343 856-862.
13. Tan JA, Hall SH, Petrusz P & French FS. Thyroid receptor activator molecule, TRAM-1, is an androgen receptor coactivator. Endocrinology 2000 141 3440-3450.
14. Hayashi Y, Yamamoto M, Ohmori S, Kikumori T, Imai T, Funahashi H et al. Polymorphism of homopolymeric glutamines in coactivators for nuclear hormone receptors. Endocrine Journal 1999 46 279-284.
15. Shibata A, Hayashi Y, Imai T, Funahashi H, Nakao A & Seo H. Somatic gene alteration of AIB1 gene in patients with breast cancer. Endocrine Journal 2001 48 199-204.
16. Rebbeck TR, Wang Y, Kantoff PW, Krithivas K, Neuhausen SL, Godwin AK et al. Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Research 2001 61 5420-5424.
17. Platz EA, Giovanucci E, Brown M, Cieluch C, Shepard TF, Stampfer MJ et al. Amplified in breast cancer-1 glutamine repeat and prostate cancer risk. Prostate Journal 2000 2 27-32.
18. Hsing AW, Chokkalingam AP, Gao YT, Wu G, Wang X, Deng J et al. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study. Cancer Epidemiology Biomarkers and Prevention 2002 11 337-341.
19. Richards RI. Dynamic mutations: a decade of unstable expanded repeats in human genetic disease. Human Molecular Genetics 2001 10 2187-2194.
20. Hughes RE. Polyglutamine disease: acetyltransferases awry. Current Biology 2002 12 141-143.